Cargando…

Engineering hybrid exosomes by membrane fusion with liposomes

Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yuko T., Umezaki, Kaori, Sawada, Shinichi, Mukai, Sada-atsu, Sasaki, Yoshihiro, Harada, Naozumi, Shiku, Hiroshi, Akiyoshi, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766490/
https://www.ncbi.nlm.nih.gov/pubmed/26911358
http://dx.doi.org/10.1038/srep21933
_version_ 1782417676063211520
author Sato, Yuko T.
Umezaki, Kaori
Sawada, Shinichi
Mukai, Sada-atsu
Sasaki, Yoshihiro
Harada, Naozumi
Shiku, Hiroshi
Akiyoshi, Kazunari
author_facet Sato, Yuko T.
Umezaki, Kaori
Sawada, Shinichi
Mukai, Sada-atsu
Sasaki, Yoshihiro
Harada, Naozumi
Shiku, Hiroshi
Akiyoshi, Kazunari
author_sort Sato, Yuko T.
collection PubMed
description Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membrane-engineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems.
format Online
Article
Text
id pubmed-4766490
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47664902016-03-02 Engineering hybrid exosomes by membrane fusion with liposomes Sato, Yuko T. Umezaki, Kaori Sawada, Shinichi Mukai, Sada-atsu Sasaki, Yoshihiro Harada, Naozumi Shiku, Hiroshi Akiyoshi, Kazunari Sci Rep Article Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze–thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membrane-engineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems. Nature Publishing Group 2016-02-25 /pmc/articles/PMC4766490/ /pubmed/26911358 http://dx.doi.org/10.1038/srep21933 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Sato, Yuko T.
Umezaki, Kaori
Sawada, Shinichi
Mukai, Sada-atsu
Sasaki, Yoshihiro
Harada, Naozumi
Shiku, Hiroshi
Akiyoshi, Kazunari
Engineering hybrid exosomes by membrane fusion with liposomes
title Engineering hybrid exosomes by membrane fusion with liposomes
title_full Engineering hybrid exosomes by membrane fusion with liposomes
title_fullStr Engineering hybrid exosomes by membrane fusion with liposomes
title_full_unstemmed Engineering hybrid exosomes by membrane fusion with liposomes
title_short Engineering hybrid exosomes by membrane fusion with liposomes
title_sort engineering hybrid exosomes by membrane fusion with liposomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766490/
https://www.ncbi.nlm.nih.gov/pubmed/26911358
http://dx.doi.org/10.1038/srep21933
work_keys_str_mv AT satoyukot engineeringhybridexosomesbymembranefusionwithliposomes
AT umezakikaori engineeringhybridexosomesbymembranefusionwithliposomes
AT sawadashinichi engineeringhybridexosomesbymembranefusionwithliposomes
AT mukaisadaatsu engineeringhybridexosomesbymembranefusionwithliposomes
AT sasakiyoshihiro engineeringhybridexosomesbymembranefusionwithliposomes
AT haradanaozumi engineeringhybridexosomesbymembranefusionwithliposomes
AT shikuhiroshi engineeringhybridexosomesbymembranefusionwithliposomes
AT akiyoshikazunari engineeringhybridexosomesbymembranefusionwithliposomes